China National Medicines (SHSE:600511) Cash-to-Debt : 17.03 (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is China National Medicines Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. China National Medicines's cash to debt ratio for the quarter that ended in Mar. 2024 was 17.03.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, China National Medicines could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for China National Medicines's Cash-to-Debt or its related term are showing as below:

SHSE:600511' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.89 Med: 6.85 Max: No Debt
Current: 17.03

During the past 13 years, China National Medicines's highest Cash to Debt Ratio was No Debt. The lowest was 1.89. And the median was 6.85.

SHSE:600511's Cash-to-Debt is ranked better than
80.41% of 97 companies
in the Medical Distribution industry
Industry Median: 0.79 vs SHSE:600511: 17.03

China National Medicines Cash-to-Debt Historical Data

The historical data trend for China National Medicines's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

China National Medicines Cash-to-Debt Chart

China National Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

10.22

7.76

10.26

17.27

19.96

China National Medicines Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															15.95	17.34	18.33	19.96	17.03

Competitive Comparison of China National Medicines's Cash-to-Debt

For the Medical Distribution subindustry, China National Medicines's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China National Medicines's Cash-to-Debt Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Medicines's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where China National Medicines's Cash-to-Debt falls into.

China National Medicines Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

China National Medicines's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	10925.539	/	(342.429	+	205.076)
	=	19.96

China National Medicines's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	9294.802	/	(263.486	+	282.174)
	=	17.03

China National Medicines (SHSE:600511) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

China National Medicines Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of China National Medicines's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Medicines (SHSE:600511) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Medicines Corp Ltd (SHSE:600511) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12 A, Sanyuan West Lane, Yongwai, Chongwen District, Beijing, CHN, 100077

Website

http://www.cncm.com.cn

China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics, and biochemical drugs.

China National Medicines (SHSE:600511) Headlines

No Headlines